A Patient Developing Both Myocardial Infarction and Stroke after COVID-19 Pneumonia

Case Report | DOI: https://doi.org/10.31579/2641-0419/181Copyright

A Patient Developing Both Myocardial Infarction and Stroke after COVID-19 Pneumonia

  • Felicia Hasta 1*
  • Mukul Anand 1
  • Laura Strong 1
  • Sarabjeet Singh-Chhabra 1
  • 1* Central Cardiology Medical Clinic, Bakersfield, CA

*Corresponding Author: Felicia Hasta, Central Cardiology Medical Clinic, Bakersfield, CA

Citation: Felicia Hasta., Mukul Anand., Laura Strong., Sarabjeet Singh-Chhabra., (2021) Case Report: A Patient Developing Both Myocardial Infarction and Stroke After COVID-19 Pneumonia. J. Clinical Cardiology and Cardiovascular Interventions, 4(11); Doi:10.31579/2641-0419/181

Copyright: © 2021 Felicia Hasta, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 06 May 2021 | Accepted: 17 May 2021 | Published: 24 May 2021

Keywords: covid; stroke; myocardial infarction; COVID-19; cardiovascular

Abstract

We herein report an unusual case of a patient developing both cardiovascular and cerebrovascular sequelae to COVID-19 pneumonia. While COVID patients have been reported to experience one or the other, there has been little discussion of the presentation and pathophysiology of a patient presenting with injury to both organ systems. This article will consider the pathophysiology common to cardiovascular and cerebrovascular injury in the setting of COVID as well mechanisms that affect each system separately. It also discusses useful investigations which may assist in diagnosis and treatment of patients presenting as such.

Case Presentation

The case presented is of a 67-year-old male who suffered a myocardial infarction (MI) and left-sided stroke following COVID-19 pneumonia. The patient has a history of lymphoma, hypertension (well-controlled by furosemide), and hyperlipidemia (controlled by diet and atorvastatin) but no prior history of coronary artery disease (CAD).

The patient was initially admitted from the emergency department (ED) due to fever, chills, and dyspnea upon exertion. He tested positive for COVID-19 and was treated with 1 unit convalescent COVID-19 plasma 2 days after admission. Lethargy and confusion increased progressively during this time. It became evident that the patient had an altered mental status secondary to acute metabolic encephalopathy. The patient required endotracheal intubation and mechanical ventilation due to worsening shortness of breath 5 days prior to admission. A chest computed tomography (CT) angiogram with contrast was performed which concluded in findings consistent with bilateral pneumonia. He was treated with intravenous (IV) remdesivir, antibiotics, dexamethasone, and acute coronary syndrome (ACS) protocol for troponin elevation.

The patient’s chest pain and elevated troponins (1.87, normal is <0.03) required further investigation with transthoracic echocardiogram (ECHO). The procedure revealed an ejection fraction (EF) of 45-50% along with mild left ventricular (LV) systolic dysfunction and wall motion abnormality. While there was no other stenosis or regurgitation, findings of hemodynamic instability indicated a 2D ECHO on the 11th day of hospitalization. The procedure revealed LV diastolic dysfunction, tricuspid valve regurgitation, and mitral valve regurgitation. These findings were supported by an electrocardiogram (EKG) which indicated left atrial (LA) enlargement and left axis deviation. The patient later suffered complications of MI in the left anterior descending artery (LAD).

The patient also had imaging studies consistent with left-sided cerebrovascular accident (CVA).

The patient was discharged to home after a two month period of hospitalization. Follow up chest x-ray 35 days after discharge demonstrated bilateral interstitial scarring but no signs of pneumonia, pericardial effusion, or pleural effusion. Due to elevated troponins, outpatient workup was recommended to consider occlusive CAD as a differential once he achieved hemodynamic stability.

Discussion

While COVID-19 pneumonia has been linked to both neurological and cardiovascular complications individually, this patient notably experienced ischemic injury to both systems.

The association between COVID-19 and cerebrovascular events has been well documented.

A study of COVID-19 infected patients in New York reported that 0.9% of hospitalized COVID patients suffered ischemic stroke, with cryptogenic strokes occurring twice as often in these patients than in non-COVID patients. [1] Further studies found that the COVID patients experiencing strokes and large vessel occlusion tended to be younger and with less cardiac comorbidities than non-COVID patients with the same neurovascular conditions. [1] The patient described in this study is a notable exception as he is of the average age of stroke patients and did suffer a cardiac comorbidity.

However, an analysis of data collected from December 2019-April 2020 found that 1.3% of COVID positive patients developed acute ischemic stroke, with many being older and with cardiac comorbidities as in this patient. Specifically, it reported that the risk of MI was higher in patients with COVID-related stroke than in COVID patients who did not suffer a stroke (10.7% vs. 4.6%, P=0.003). (2) This analysis found that COVID patients who developed acute ischemic stroke tended to be older, Black, and have been previously diagnosed with hypertension, diabetes, hyperlipidemia, atrial fibrillation, or congestive heart failure. [2] The patient reported here is 67 years old, Caucasian, and suffers from hyperlipidemia and hypertension, fitting many of the criteria put forth by this study. The same analyses also found that COVID patients who developed acute ischemic stroke also tended to suffer cardiovascular events during the same hospitalization. However, unlike this subject patient, the analyses showed a tendency toward multisystem involvement including acute kidney injury and hepatic failure. [2] This analysis concluded that while COVID-19 was a predisposing factor, the risk of acute ischemic stroke was mainly found in patients who were already at risk for stroke due to other medical risk factors.

Many mechanisms have been proposed to explain COVID-related cerebrovascular events, including hypercoagulability due to cytokine storm and direct viral-induced endotheliopathy. ACE2, a protein found on lung epithelial cells which breaks down pro-inflammatory factor angiotensin II, has been proposed as the entry site for the SARS-CoV-2 viral particle. [1] ACE2 is also expressed in cardiomyocytes and astrocytes, allowing for direct viral invasion of the heart and brain respectively. [3] The inhibition of ACE2 by viral particles may thus allow systemic inflammation and cytokine storm, resulting in dysfunction in multiple organ systems and blood vessels. These inflammatory changes to blood vessels result in activation of the coagulation cascade and subsequent elevation of inflammatory markers. One such unifying factor in affected patients is elevation of D-dimers, which was reported in more than 90% of COVID-associated stroke patients in New York. [1] Another such finding is elevations in inflammatory markers IL-6 and C-reactive protein (CRP) as a result of cytokine storm, a proposed mechanism of COVID-associated thrombosis associated with both MI and stroke in patients without a prior history. [1] This patient had elevated inflammatory markers, coagulation factors, and troponins which are summarized in the table below.

Table 1: Lab results of the subject patient upon admission to and nearing discharge from the hospital

 Normal values are indicated in the parentheses next to each parameter. Troponins were elevated upon admission reflecting ongoing MI. Many inflammatory (ESR, CRP) and coagulation (D-Dimers, PT) markers were elevated upon admission and remained high at discharge, illustrating ongoing inflammatory consequences of COVID-19. Two coagulation markers, PTT and INR remained normal. Other markers of ongoing infection (LDH, ferritin) were also elevated upon admission.

There have been multiple reported manifestations of cardiac complications due to COVID-19, including myocarditis, MI, heart failure, arrhythmias, and thromboembolic events. Because such cardiac manifestations are common, measurement of cardiac enzymes such as troponins is recommended for all patients hospitalized with COVID-19 by the Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment as well the World Health Organization (WHO). [4] Other organizations, such as the American College of Cardiology recommend only measuring these enzymes only if clinically indicated. The patient discussed here did in fact have elevated troponins in the ED, requiring follow up investigation with ECHO. [4]

Many COVID patients who raised strong clinical suspicion for MI (based on symptoms, elevated serum troponins, and ECG findings) were later found to have acute myocarditis. ECHO allowed distinction between these two conditions, with findings of focal wall motion abnormalities in acute coronary syndromes (ACS) and either normal findings or global dysfunction in myocarditis. The ECHO performed on the patient in this study was consistent with ACS/MI as it demonstrated left ventricular wall and atrioventricular valve dysfunction. [4]

Figure 1: The patient’s EKG at presentation to the ED

Interpretation is significant for probable LA enlargement (enlargement of P waves in leads II and V1, denoted by bold arrows) and left axis deviation (positive QRS in lead I and negative in leads II and avF, denoted by dashed arrows), which supports ECHO findings of mitral regurgitation and LV wall motion abnormality. Borderline T wave flattening/depression in the anterior leads (long arrows in leads V2 and V3) reflects ischemia in the areas supplied by the LAD.

The proposed mechanisms of cardiovascular injury due to COVID-19 are similar to those for COVID-related stroke: a combination of immunogenic hypercoagulability and direct viral-induced damage. However, more recent research also emphasized the likelihood of direct viral damage to cardiac tissue due to viral binding of surface ACE2 protein, as mentioned above. Autopsy samples from a Toronto study showed SARS-CoV viral RNA in 35% of the hearts of expired COVID patients. In the analysis that followed, it was found that every sample where viral RNA was detected showed signs of myocardial inflammation, suggesting the presence of the virus resulted in cardiomyopathy every time. [5]

These pathophysiologies, either individually or in combination, most commonly result in Type I or Type 2 MI as defined by the Fourth Universal Definition of MI. [7] A type 1, or spontaneous MI is “due to acute coronary atherothrombotic myocardial injury with either plaque rupture or erosion and, often, associated thrombosis.”[8]. Plaque rupture or erosion in the setting of COVID can be achieved through either direct viral-induced endothelial dysfunction as defined above or indirectly through inflammation-induced hypercoagulability. [4] Type 2 MI, defined as an infarction resulting from a mismatch in oxygen supply and demand is also possible through a number of mechanisms. These include decreased perfusion from atherosclerosis, endothelial dysfunction and vasoconstriction from increased angiotensin II (a result of ACE inhibition), and hypoxemia from acute respiratory distress syndrome (ARDS) in COVID pneumonia. [7]

As discussed, three mechanisms, or “pathways” are common to cardiovascular and cerebrovascular injury in COVID patients. The first, described as the “hypoxia pathway” suggests that ARDS in COVID patients results in hypoxia in both myocardial and neuronal cells, resulting in ischemic injury to both organs. The second “RAAS (renin angiotensin aldosterone system) pathway” is a result of viral ACE2 inhibition, resulting in increased systemic angiotensin II and subsequent endothelial dysfunction in both the heart and brain. The third, or “immune pathway” describes the effect of pneumonia-induced systemic inflammatory response (SIRS), resulting in proinflammatory cytokine storm which cause plaque instability and rupture in the heart and brain. [3]

Conclusion

Because of the common mechanisms in COVID injury to the heart and brain, it makes sense that a small number of patients, such as this one, experienced injury to both systems while hospitalized with COVID-19 pneumonia. Unfortunately, there is limited data from such cases readily available, and the few patients that have been reported ultimately died of their injuries [9]. This study is consequently limited as it cannot be compared to surviving patients with the same presentation. However, thorough review of the events and findings in the case presented here may have prognostic value in future cases of patients who present similarly. To assist in recognizing potential patients, it may be helpful to obtain an ECHO (to assess for wall motion abnormality and other acute findings), CT head (to assess for ischemic brain injury), and levels of troponins, inflammatory and coagulation markers. Another limitation is loss to follow up, as the patient did not complete scheduled outpatient appointments after hospital discharge. However, it was recommended the patient receive follow up CT head and ECHO to assess any long-term changes in the heart and brain.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad